Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665.

Clinical impact of ABL1 kinase domain mutations and IKZF1 deletion in adults under age 60 with Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL): molecular analysis of CALGB (Alliance) 10001 and 9665. Leuk Lymphoma. 2016 10; 57(10):2298-306.

View in: PubMed

subject areas

Adult
Biomarkers, Tumor
DNA Mutational Analysis
Female
Fusion Proteins, bcr-abl
Gene Deletion
Humans
Ikaros Transcription Factor
Leukocyte Count
Male
Middle Aged
Mutation
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Prognosis
Protein Interaction Domains and Motifs
Proto-Oncogene Proteins c-abl
Survival Analysis
Young Adult

authors with profiles

Wendy Stock
Richard A. Larson